Table 2.
Discovery | Validation | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Total (N=556) | No PoAF (N=391) | PoAF (N=165) | P value | Total (N=1164) | No PoAF (N=828) | PoAF (N=336) | P value | Between cohort P value | ||
Chr. 1q21 | rs13376333 (C/T) | 30.3% | 28% | 35.8% | 0.04 | 29.6% | 28.7% | 31.8% | 0.24 | 0.74 |
rs6666258 (G/C) | 30.8% | 28% | 37.3% | 0.01 | 25% | 24.2% | 27.2% | 0.06 | <0.001 | |
Chr. 1q24 | rs3903239 (G/A) | 39.1% | 38.7% | 40% | 0.80 | 56.8% | 57.9% | 54.3% | 0.14 | <0.001 |
Chr. 4q25 | rs2200733 (C/T) | 11.1% | 10.5% | 12.4% | 0.62 | 12.8% | 10.7% | 17.9% | <0.001 | 0.25 |
Chr. 7q31 | rs3807989 (G/A) | 45.1% | 44.2% | 47.3% | 0.55 | 41% | 41% | 41.1% | 0.90 | 0.009 |
Chr. 9q22 | rs10821415 (C/A) | 37.2% | 36.6% | 38.8% | 0.80 | 44.3% | 44.3% | 44.2% | 0.53 | 0.001 |
Chr. 10q22 | rs10824026 (A/G) | 18.8% | 19.6% | 17% | 0.17 | 15.5% | 16.7% | 12.6% | 0.02 | 0.05 |
Chr. 14q23 | rs1152591 (G/A) | 42.5% | 42.7% | 42.1% | 0.70 | 47.7% | 48.3% | 46.3% | 0.52 | 0.02 |
Chr. 16q22 | rs2106261 (G/A) | 17.9% | 17.8% | 18.2% | 0.44 | 14.4% | 13.4% | 17% | 0.04 | 0.01 |
rs7193343 (C/T) | 16.5% | 16.2% | 17% | 0.94 | 15.3% | 14.4% | 17.6% | 0.16 | 0.57 |
PoAF: Postoperative atrial fibrillation